Financials in USD. Standardized financial statements.
A compact view of how Twist Bioscience Corporation turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $376.57M | $312.97M | $245.11M | $203.56M | $132.33M | $90.10M | $54.38M | $25.43M | $10.77M | $2.27M |
| Revenue Growth? | +20.3% | +27.7% | +20.4% | +53.8% | +46.9% | +65.7% | +113.9% | +136.2% | +374.5% | 0.0% |
| Cost of Revenue? | $185.57M | $179.63M | $155.38M | $119.33M | $80.62M | $61.41M | $47.43M | $32.19M | $24.02M | $9.42M |
| Gross Profit? | $191.00M | $133.35M | $89.73M | $84.23M | $51.71M | $28.69M | $6.96M | -$6.76M | -$13.25M | -$7.15M |
| Gross Margin? | +50.7% | +42.6% | +36.6% | +41.4% | +39.1% | +31.8% | +12.8% | -26.6% | -123.1% | -315.2% |
| Operating Expenses? | $327.26M | $354.18M | $306.89M | $319.01M | $204.44M | $168.77M | $115.81M | $63.80M | $45.23M | $36.50M |
| Operating Income? | -$136.26M | -$220.83M | -$217.16M | -$234.78M | -$152.73M | -$140.08M | -$108.85M | -$70.56M | -$58.48M | -$43.66M |
| EBITDA? | -$52.10M | -$176.71M | -$174.15M | -$211.68M | -$143.91M | -$132.09M | -$99.77M | -$63.95M | -$53.10M | -$39.11M |
| Income Before Tax | -$76.95M | -$208.17M | -$203.47M | -$228.27M | -$154.03M | -$139.55M | -$107.38M | -$70.99M | -$59.03M | -$44.09M |
| Income Tax Expense | $719,000 | $560,000 | $1.15M | -$10.41M | -$1.93M | $382,000 | $292,000 | $242,000 | $280,000 | $0 |
| Net Income? | -$77.67M | -$208.73M | -$204.62M | -$217.86M | -$152.10M | -$139.93M | -$107.67M | -$71.24M | -$59.31M | -$44.09M |
| EPS? | $-1.30 | $-3.60 | $-3.60 | $-4.04 | $-3.15 | $-3.57 | $-3.92 | $-2.68 | $-3.16 | $-2.35 |
| Diluted EPS? | $-1.30 | $-3.60 | $-3.60 | $-4.04 | $-3.15 | $-3.57 | $-3.92 | $-2.68 | $-3.16 | $-2.35 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality